PELLECCHIA, Maria Teresa
 Distribuzione geografica
Continente #
AS - Asia 16.701
NA - Nord America 10.147
EU - Europa 3.594
SA - Sud America 1.275
AF - Africa 157
OC - Oceania 90
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.967
Nazione #
HK - Hong Kong 11.102
US - Stati Uniti d'America 9.925
SG - Singapore 2.528
CN - Cina 1.133
BR - Brasile 947
VN - Vietnam 896
IT - Italia 805
RU - Federazione Russa 538
UA - Ucraina 530
DE - Germania 362
IE - Irlanda 291
FR - Francia 248
KR - Corea 206
TR - Turchia 199
SE - Svezia 195
IN - India 155
GB - Regno Unito 151
FI - Finlandia 140
AR - Argentina 126
CA - Canada 103
BD - Bangladesh 78
JP - Giappone 76
MX - Messico 72
PL - Polonia 60
NL - Olanda 54
AU - Australia 49
EC - Ecuador 47
CO - Colombia 46
IQ - Iraq 46
AT - Austria 45
EE - Estonia 38
ZA - Sudafrica 38
NZ - Nuova Zelanda 37
ID - Indonesia 35
PK - Pakistan 35
VE - Venezuela 33
CZ - Repubblica Ceca 32
ES - Italia 32
UZ - Uzbekistan 25
CL - Cile 23
KE - Kenya 22
MA - Marocco 21
IL - Israele 20
PH - Filippine 20
SA - Arabia Saudita 20
PY - Paraguay 18
PE - Perù 15
MY - Malesia 14
JM - Giamaica 12
JO - Giordania 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
EG - Egitto 10
ET - Etiopia 10
LT - Lituania 10
UY - Uruguay 10
AZ - Azerbaigian 9
BO - Bolivia 9
LB - Libano 9
OM - Oman 9
DZ - Algeria 8
KZ - Kazakistan 8
BE - Belgio 7
NP - Nepal 7
DO - Repubblica Dominicana 6
GR - Grecia 6
PA - Panama 6
AL - Albania 5
BW - Botswana 5
KG - Kirghizistan 5
KH - Cambogia 5
TW - Taiwan 5
BG - Bulgaria 4
CH - Svizzera 4
CY - Cipro 4
HN - Honduras 4
LK - Sri Lanka 4
MN - Mongolia 4
NG - Nigeria 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BH - Bahrain 2
BS - Bahamas 2
Totale 31.916
Città #
Hong Kong 11.083
Ann Arbor 1.422
Singapore 1.200
San Jose 1.190
Chandler 730
Princeton 707
Wilmington 662
Jacksonville 658
Ashburn 620
Dallas 502
Dublin 278
Dong Ket 270
Council Bluffs 267
Beijing 249
Woodbridge 233
Houston 230
The Dalles 223
Ho Chi Minh City 214
Lauterbourg 213
Nanjing 156
Izmir 154
Moscow 148
Hanoi 142
Andover 141
Boardman 128
Naples 114
Pellezzano 109
Los Angeles 104
Dearborn 93
Salerno 90
São Paulo 86
New York 80
Tokyo 69
Santa Clara 63
Norwalk 56
Düsseldorf 55
Munich 55
Fairfield 54
Frankfurt am Main 50
Nanchang 49
Changsha 47
Hebei 46
Shenyang 45
Warsaw 44
Montreal 43
Redwood City 41
Tallinn 38
Jiaxing 36
Nuremberg 36
Pune 35
Da Nang 34
Rome 34
Rio de Janeiro 33
Orem 31
San Francisco 29
Haiphong 28
Belo Horizonte 27
Chennai 27
Mestre 27
Brooklyn 26
Amsterdam 25
Atlanta 25
Boston 24
Seattle 24
Seoul 22
Brasília 21
Brno 21
Chicago 21
Johannesburg 21
Tashkent 21
West Jordan 21
Curitiba 20
Milan 20
Stockholm 20
Denver 19
Nairobi 19
Phoenix 19
Washington 18
Buenos Aires 17
Poplar 17
Turku 17
Auckland 16
Baghdad 16
Columbus 16
Guayaquil 16
Helsinki 16
Porto Alegre 16
Tianjin 16
Shanghai 15
Guarulhos 14
Hải Dương 14
London 14
Ribeirão Preto 14
San Diego 14
Sydney 14
Ankara 13
Biên Hòa 13
Campinas 13
Casoria 13
Guangzhou 13
Totale 24.362
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.190
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.047
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 957
Sex Differences in Parkinson’s Disease: From Bench to Bedside 650
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 602
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 588
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 546
Gender differences in microRNA expression in levodopa-naive PD patients 545
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 504
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 467
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 386
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 371
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 356
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 354
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 330
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 324
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 322
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 312
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 305
A novel phenotype in an Italian family with a rare progranulin mutation 303
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 291
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 269
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 263
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 236
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 221
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 217
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 211
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 210
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 194
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 193
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 191
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 181
Postganglionic sudomotor denervation in patients with multiple system atrophy. 179
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 178
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 170
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 167
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 165
A critique of the second consensus criteria for multiple system atrophy 164
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 162
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 162
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 161
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 159
Brain anatomical substrates of mirror movements in Kallmann syndrome. 156
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 154
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 147
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 147
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 147
The natural history of multiple system atrophy: A prospective European cohort study 146
Increased bilirubin levels in de novo Parkinson's disease 145
Quitting smoking: An early non-motor feature of Parkinson's disease? 144
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 141
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 139
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 139
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 138
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 138
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 136
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 136
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 135
A genome-wide association study in multiple system atrophy 133
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 131
Sindromi parkinsoniane 131
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 131
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 129
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 127
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 125
The accuracy of the arginine growth hormone test in parkinsonism. 124
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 123
Gender and non motor fluctuations in Parkinson's disease: A prospective study 123
The alpha-synuclein gene in multiple system atrophy 122
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 122
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 122
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 120
Cross-modal connectivity effects in age-related hearing loss 119
The relevance of gender in Parkinson's disease: a review 118
Early MRI findings in acquired hepatocerebral degeneration. 116
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 114
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 114
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 113
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 113
On the relationship between side of onset and cognition in Parkinson disease 113
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 112
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 111
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 111
SNCA variants are associated with increased risk for multiple system atrophy 110
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 110
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 110
“Response to Apomorphine in early Parkinson’s disease”. 110
Cognitive correlates of “pure apathy” in Parkinson's disease 110
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 110
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 110
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 109
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 109
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 109
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 107
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 106
A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy 106
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. 105
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 105
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features 105
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 104
Totale 21.943
Categoria #
all - tutte 98.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021453 0 0 0 0 0 0 0 0 0 0 131 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202619.129 3.032 5.189 4.284 697 1.263 609 1.844 420 606 1.158 27 0
Totale 32.579